ClinicalTrials.Veeva

Menu

International Multicentric Observational Study to Characterize Subpopulations of Patients With Autism Spectrum Disorder

S

Stalicla

Status

Enrolling

Conditions

Autism Spectrum Disorder

Study type

Observational

Funder types

Industry

Identifiers

NCT05590715
STA-B-001

Details and patient eligibility

About

To determine sufficient number of biological and clinical markers to identify subgroups of potential best responders to a specific medication

Enrollment

1,500 estimated patients

Sex

All

Ages

12 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Participants previously diagnosed with ASD (DSM-5)
  • Available well-documented health records within the first 2 years of life
  • Participants must have a parent or reliable caregiver who agrees to provide information about the participant
  • Participants willing and consenting or assenting to participate.

Exclusion criteria

  • Episode of fever (i.e. ≥100.5 °F or ≥ 38 °C) or clinically significant illness without fever (as judged by the investigator), within 10 days before any study assessment.
  • If the investigator assesses any unwillingness or any medical condition that may prevent the subject from completing this study.

Trial contacts and locations

21

Loading...

Central trial contact

Eric Painbeni, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems